As organizations seek to evolve their patient support programs, five key actions can help bridge the data gap between analytics teams and patient care teams: Data will always be essential in measuring ...

Please provide your email address to receive an email when new articles are posted on . The newly presented data is from the two STOP-HS trials, both of which met their primary endpoints. Povorcitinib ...

Venetoclax-obinutuzumab therapy shows sustained PFS and OS benefits over chemoimmunotherapy in untreated CLL patients with coexisting conditions. The CLL14 trial's 6-year follow-up confirms >50% of ...